English   español  
Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/154122
Compartir / Impacto:
Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL

Pharmacological consequences of PKC inhibition on Kv1.5+Kvbeta1.3 channels

AutorCruz, Alicia de la ; Macías, Álvaro; Prieto, Ángela ; Peraza, Diego A.; Tamkun, Michael M.; González, Teresa ; Valenzuela, Carmen
Fecha de publicación2015
Citación59th Annual Meeting Biophysical Society (2015)
ResumenThe Kvß1.3 subunit modifies the gating and pharmacology of Kv1.5 channels in a PKC-dependent manner, decreasing channel sensitivity to bupivacaine- and quinidine-mediated blockade. Cardiac Kv1.5 channels associate with receptor for activated C kinase 1 (RACK1), the Kvß1.3 subunit and different PKC isoforms, resulting in the formation of a functional channelosome. The aim of the present study was to investigate the effects of PKC inhibition on bupivacaine and quinidine block of Kv1.5 + Kvß1.3 channels. HEK293 cells were transfected with Kv1.5 + Kvß1.3 channels, and currents were recorded using the whole-cell configuration of the patch-clamp technique. PKC inhibition was achieved by incubating the cells with either calphostin C or bisindolylmaleimide II and the effects of bupivacaine and quinidine were analysed. The voltage-dependent inactivation of Kv1.5 + Kvß1.3 channels and their pharmacological behavior after PKC inhibition with calphostin C were similar to those displayed by Kv1.5 channels alone. Indeed, the IC50 values for bupivacaine were similar in cells whose PKC was inhibited with calphostin C or bisindolylmaleimide II. Similar results were also observed in the presence of quinidine. The finding that the voltage-dependence of inactivation and the pharmacology of Kv1.5 + Kvß1.3 channels after PKC inhibition resembled that observed in Kv1.5 channels suggests that both processes are dependent on PKC-mediated phosphorylation. These results may have clinical relevance in diseases that are characterized by alterations in kinase activity.
DescripciónResumen del póster presentado al 59th Annual Meeting Biophysical Society, celbrado en Baltimore, Maryland (USA) del 7 al 11 de febrero de 2015.
Aparece en las colecciones: (IIBM) Comunicaciones congresos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Mostrar el registro completo

NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.